The role of HLA-DRB1 alleles on susceptibility and outcome of a Portuguese Multiple Sclerosis population

• Tipo: Artigo em Revista Científica Internacional
• Data: 2007

Autores

Ana Martins Silva (Autor) Outra; Clara Pereira (Autor) Outra; Andrela Bettencourt (Autor) Outra; Cldudia Carvalho (Autor) Outra; Ana Rita Couto (Autor) Outra; Maria Isabel Leite (Autor) Outra; Monica Marta (Autor) Outra; Marta Freijo (Autor) Outra; Paulo Pinho Costa (Autor) ICBAS; Denisa Mendonca (Autor) ICBAS; Luis Monteiro (Autor) Outra; Jdcome Bruges Armas (Autor) Outra; Berta Martins (Autor) Outra

Revista

Título: Journal of the Neurological Sciences

Vol. 258

Páginas: 69-74

ISSN: 0022-510X

Editora: Elsevier

Indexação

ISI Web of Knowledge - 31 Citações

Scopus - 36 Citações

Classificação Científica

FOS: Ciências médicas e da saúde > Medicina clínica

Outras Informações

ID Authenticus: P-004-8TK

DOI: 10.1016/j.jns.2007.02.033

Abstract (EN): Background: The association between susceptibility to multiple sclerosis (MS) and HLA-DRB1*15 has been reported in various European populations. Objective: To investigate the relationship between MS, HLA-DRB1*15 and other DRB1 alleles in a Portuguese population and their association with clinical course of MS. Methods: The HLA-DRB1 alleles were analyzed by PCR-SSP in 248 MS patients and 282 healthy controls. In order to relate HLA-DRB1 alleles to disease aggressiveness, patients with relapsing remitting MS and secondary progressive MS were subdivided into 3 groups: 'benign' MS patients who maintain an Extended Disability Status Scale (EDSS) score of : 3 at least 10 years after disease onset; non-benign MS patients with EDSS > 3 after the same period and 'aggressive' MS those with EDSS = 6 within 15 years of disease onset. Results: As expected, a higher frequency of HLA-DRB1*15 was found in MS patients (29.8% vs 19.9%, odds ratio (OR) = 1.72, 95% CI= 1.15-2.56, p = 0.008). The HLA-DRB1*03 allele was positively associated with MS in the overall patient population (22.6% vs 15.6%, OR= 1.58,95% CI= 1.022.45). Concerning disease aggressiveness, HLA-DRB1*15 occurred more frequently in the group with benign disease (42.6% vs 19.9%, OR= 2.99, 95% CI = 1.56-5.72) and in the group with non-benign disease (34.1 % vs 19.9%, OR= 2.09, 95% CI = 1.05-4.16) compared with controls. When time to reach an EDSS = 3 or EDSS = 6 was considered as end point, HLA-DRB1*15 negative patients were found to have a worse prognosis. Conclusions: In this population of Portuguese MS patients, the HLA-DRB1*15 allele is established as a genetic marker for susceptibility to MS and is also associated with a better outcome.

Idioma: Inglês

Tipo (Avaliação Docente): Científica

Nº de páginas: 6